Home » Blog » Analysis of CMS’s Oncology Care Model

Analysis of CMS’s Oncology Care Model


IP Blog | Dave Melin | March 2, 2015

BioBlog Weekly oncologyThis week in healthcare, updates on CMS’s new Oncology Care Model and how Obamacare pits insurers against the medical industry.

Bringing the Oncology Care Model into Focus

In this brief-but-detailed article, ACCC dives into clarifying some of the finer points of CMS’s recently-announced Oncology Care Model, including specifics about payments, participation in the program, and potential benefits.

How Obamacare pits insurers against the medical industry

In this opinion piece, Dr. Scott Gottlieb argues that Obamacare’s tight regulation may back medical industry players into a corner: “With insurers’ ability to raise premiums tightly controlled by Washington, and with new costs imposed through federal mandates that regulate what they must cover, the plans are going to be increasingly pressed to find political justification for premium hikes.”

Docs Don’t Need Fixing — Medicare Does

In this Forbes piece, American Medical Association President Robert M. Wah writes urging Congress to enact SGR reform now rather than continuing to string along the policy with “patches” that don’t really solve the problem. “Permanently eliminating the SGR would not only create greater certainty and stability for patients to access Medicare, it would also provide financial stability for physicians, freeing them to implement innovative health care delivery and payment models across the country that are already proving successful in reducing costs and increasing access to high-quality care.”

How payers can speed up the claims process

In the quest to speed the claims process there are many hurdles. But this article offers payers three strategies to help overcome the hurdles: “establish a phase-wide approach”, “create a master patient index”, and “aggregate the data”.

At least 6 Republican states revisit their stance of resisting Obamacare

When Obamacare first past, many Republican states loudly denounced it and refused to participate. But now, even as the Supreme Court is deciding on whether to continue federal subsidies, the Washington Post notes that “at least six states where ­Republican leaders had previously refused to set up state marketplaces under the Affordable Care Act are now considering what steps they might take to preserve the subsidies being paid to their residents.”

Want more health care landscape updates and insights? Follow us on Twitter @innovpartners.


Topics in this Post:



Leave a Comment

Your email address will not be published. Required fields are marked *